| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |